Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Donelan
Antitumor Activity of the Selective Pan-Raf Inhibitor TAK-632 in BRAF Inhibitor-Resistant Melanoma
Cancer Research
Cancer Research
Oncology
A Case of Cerebro-Spinal Meningitis: Lumbar Puncture: Recovery
BMJ
Related publications
BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in BRAF-Mutated Colorectal Cancers
Molecular Cancer Therapeutics
Cancer Research
Oncology
Antitumor Properties of RAF709, a Highly Selective and Potent Inhibitor of RAF Kinase Dimers, in Tumors Driven by Mutant RAS or BRAF
Cancer Research
Cancer Research
Oncology
Antitumor Activity of Selective MEK1/2 Inhibitor AZD6244 in Combination With PI3K/mTOR Inhibitor BEZ235 in Gefitinib-Resistant NSCLC Xenograft Models
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Rogaratinib: A Potent and Selective Pan-FGFR Inhibitor With Broad Antitumor Activity in FGFR-overexpressing Preclinical Cancer Models
International Journal of Cancer
Cancer Research
Oncology
Antitumor Activity of the Polo-Like Kinase Inhibitor, TAK-960, Against Preclinical Models of Colorectal Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Autophagy Modulation in MEK Inhibitor-Resistant Melanoma
British Journal of Dermatology
Dermatology
Medicine
A New B-Raf Inhibitor Combo for Advanced Melanoma
Oncotarget
Oncology
Combination Therapy Targeting the Elevated Interleukin-6 Level Reduces Invasive Migration of BRAF Inhibitor-Resistant Melanoma Cells
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Discovery of a Selective Inhibitor of Oncogenic B-Raf Kinase With Potent Antimelanoma Activity
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary